Development Trend and Investment Prospect of Intelligent Medication Management in China

Abstract

With the implementation of the policy of “hierarchical diagnosis and treatment” in China and the gradual establishment of local medical associations, the service capacity of basic medical and health institutions has been improved, and some patients with common diseases will make more use of primary medical resources to relieve the overload of leading hospitals, thus giving rise to the extensive demand for the information management system of primary medical and health institutions, and promoting the expansion of the downstream market of the industry. Catalyzed by the epidemic, new domestic bases are expected to further drive the expansion of the intelligent medication management industry. Therefore, this paper analyzes the current development status of this industry including analysis on which specific area is now the most profitable and which one has the greatest potential in the future. The analysis also includes plights, new trends, and market demands in the industry. Most importantly, the main target is to discuss the prospect of development and potential in investment in this industry in China.